Barely Significant
← all excerpts

SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial.

Int J Hematol Oncol Stem Cell Res · 2018 · PMC6141429 · PMID 30233767

Europe PMC
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

only marginally significantP=0.07so close (0.05 < p ≤ 0.1)
Moreover, there was a trend toward lower incidence of grade II-III chronic GvHD in the intervention arm, but the difference was only marginally significant (34.0% vs. 48.9%, P=0.07; Table 2 ).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.